Component information
No US or EU label exists for this exact combination, so information is shown for each component.
Use: INDICATIONS AND USAGE Folic acid, USP is effective in the treatment of megaloblastic anemias due to a deficiency of folic acid, USP (as may be seen in tropical or nontropical sprue) and in anemias of nutritional origin… US FDA label
Use: Peripheral neuropathy (adults, oral) renalcarematters.com, reviewed
Kidney dosing: Mecobalamin (single-agent)Show full dosing details
- CrCl ≥60 mL/min
- Usual oral dose: 1,500 micrograms/day in 3 divided doses (500 micrograms three times daily); reassess if no effect after several months (PMDA insert).
- CrCl 30–59 mL/min
- No dose adjustment. A Japanese regulatory review of high-dose intramuscular mecobalamin (50 mg twice weekly) found AUC about 1.2-fold (mild, n=4) and 1.6-fold (moderate, n=3) versus a single normal subject; there are no PK data in severe impairment. PMDA concluded no dose adjustment is needed. Extrapolated to oral 1,500 micrograms/day (judgment); the oral tablet insert does not address kidney function.
- CrCl 15–29 mL/min
- No dose adjustment. A Japanese regulatory review of high-dose intramuscular mecobalamin (50 mg twice weekly) found AUC about 1.2-fold (mild, n=4) and 1.6-fold (moderate, n=3) versus a single normal subject; there are no PK data in severe impairment. PMDA concluded no dose adjustment is needed. Extrapolated to oral 1,500 micrograms/day (judgment); the oral tablet insert does not address kidney function.
- CrCl <15 mL/min (not on dialysis)
- No dose adjustment. A Japanese regulatory review of high-dose intramuscular mecobalamin (50 mg twice weekly) found AUC about 1.2-fold (mild, n=4) and 1.6-fold (moderate, n=3) versus a single normal subject; there are no PK data in severe impairment. PMDA concluded no dose adjustment is needed. Extrapolated to oral 1,500 micrograms/day (judgment); the oral tablet insert does not address kidney function.
- Hemodialysis (intermittent)
- No dialysis data in the Japanese sources.
- Peritoneal dialysis
- No dialysis data.
- CRRT
- No data.
- Dialyzable? Not stated.
- Monitoring Clinical response in peripheral neuropathy; do not continue for months without benefit (PMDA insert).
From the Mecobalamin monograph (renalcarematters.com, reviewed).
Use: INDICATIONS AND USAGE: Pyridoxine Hydrochloride Injection is effective for the treatment of pyridoxine deficiency as seen in the following: Inadequate dietary intake. US FDA label
Use: INDICATIONS Thiamine Hydrochloride Injection is effective for the treatment of thiamine deficiency or beriberi whether of the dry (major symptoms related to the nervous system) or wet (major symptoms related to the… US FDA label
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Capsule: 200 mg/50 mg/500 mcg/5 mg
Registered products in the Philippines
1 product registered with the Food and Drug Administration (FDA) Philippines list Folic acid + Mecobalamin + Pyridoxine + Thiamine as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
Foliage MaxThiamine Nitrate (Vitamin B1) + Pyridoxine Hydrochloride (Vitamin B6) + Mecobalamin (Vitamin B12) + Folic Acid | 200 mg/50 mg/500 mcg/5 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | Drugmaker's Laboratories, Inc.Philippines | Trader: Terramedic, Inc. | DR-XY45016 | Jan 29, 2031 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .